ETANERCEPT (ETN) - ANVISA Registration 80134860236
Access comprehensive regulatory information for ETANERCEPT (ETN) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860236 and manufactured by PROGENIKA BIOPHARMA S.A.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including IMMUNDIAGNOSTIK, PROGENIKA BIOPHARMA S.A., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80134860236
25351310802201653
02513899000171
Company Information
Dates and Status
Jul 03, 2017
VIGENTE
09/18/2025 19:00:01
ANTI-ADALIMUMAB ANTIBODIES (ADL)
PROMONITOR ANTI-ADL
PROGENIKA BIOPHARMA S.L.
80134860235
Jul 03, 2017
ANTI-INFLIXIMAB (IFX) ANTIBODIES
PROMONITOR ANTI-IFX
PROGENIKA BIOPHARMA S.L.
80134860239
Jul 03, 2017
ANTI-ADALIMUMAB ANTIBODIES (ADL)
IDKmonitor® Adalimumab free ADA ELISA
IMMUNDIAGNOSTIK
80464810759
Feb 11, 2021
ANTI-ADALIMUMAB ANTIBODIES (ADL)
IDKmonitor® Adalimumab total ADA ELISA
IMMUNDIAGNOSTIK
80464810760
Feb 11, 2021
ANTI-INFLIXIMAB (IFX) ANTIBODIES
LISA-TRACKER ANTI-INFLIXIMAB
BIOSYNEX SA
10338930315
Jul 22, 2024